These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11310690)

  • 1. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?
    Raad I; Hanna HA; Awad A; Alrahwan A; Bivins C; Khan A; Richardson D; Umphrey JL; Whimbey E; Mansour G
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):136-9. PubMed ID: 11310690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.
    Matlow AG; Kitai I; Kirpalani H; Chapman NH; Corey M; Perlman M; Pencharz P; Jewell S; Phillips-Gordon C; Summerbell R; Ford-Jones EL
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):487-93. PubMed ID: 10432161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management.
    Maki DG; Stolz SS; Wheeler S; Mermel LA
    Crit Care Med; 1994 Nov; 22(11):1729-37. PubMed ID: 7956275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters.
    Rickard CM; Lipman J; Courtney M; Siversen R; Daley P
    Infect Control Hosp Epidemiol; 2004 Aug; 25(8):650-5. PubMed ID: 15357156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing for intravenous administration set replacement.
    Gillies D; O'Riordan L; Wallen M; Morrison A; Rankin K; Nagy S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003588. PubMed ID: 16235329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
    León C; Alvarez-Lerma F; Ruiz-Santana S; González V; de la Torre MV; Sierra R; León M; Rodrigo JJ
    Crit Care Med; 2003 May; 31(5):1318-24. PubMed ID: 12771597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.
    Maki DG; Botticelli JT; LeRoy ML; Thielke TS
    JAMA; 1987 Oct; 258(13):1777-81. PubMed ID: 3114506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between replacement at 4 days and 7 days of the infection rate for pulmonary artery catheters in an intensive care unit.
    Chen YY; Yen DH; Yang YG; Liu CY; Wang FD; Chou P
    Crit Care Med; 2003 May; 31(5):1353-8. PubMed ID: 12771602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing i.v. administration sets: is 48 versus 24 hours safe for neutropenic patients with cancer?
    deMoissac D; Jensen L
    Oncol Nurs Forum; 1998 Jun; 25(5):907-13. PubMed ID: 9644707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious complications with nondaily versus daily infusion of intravenous fat emulsions in non-critically ill adults.
    Chheng ML; Heidbreder C; Btaiche IF; Blackmer AB
    Nutr Clin Pract; 2013 Dec; 28(6):737-44. PubMed ID: 24192265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherally inserted central venous catheter-associated bloodstream infections in hospitalized adult patients.
    Ajenjo MC; Morley JC; Russo AJ; McMullen KM; Robinson C; Williams RC; Warren DK
    Infect Control Hosp Epidemiol; 2011 Feb; 32(2):125-30. PubMed ID: 21460466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy.
    Danzig LE; Short LJ; Collins K; Mahoney M; Sepe S; Bland L; Jarvis WR
    JAMA; 1995 Jun; 273(23):1862-4. PubMed ID: 7776503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of intravenous administration set changes: a systematic review.
    Gillies D; O'Riordan L; Wallen M; Rankin K; Morrison A; Nagy S
    Infect Control Hosp Epidemiol; 2004 Mar; 25(3):240-50. PubMed ID: 15061417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of central venous catheter dressings in bone marrow transplant recipients.
    Brandt B; DePalma J; Irwin M; Shogan J; Lucke JF
    Oncol Nurs Forum; 1996 Jun; 23(5):829-36. PubMed ID: 8792352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system.
    Loftus RW; Brindeiro BS; Kispert DP; Patel HM; Koff MD; Jensen JT; Dodds TM; Yeager MP; Ruoff KL; Gallagher JD; Beach ML; Brown JR
    Anesth Analg; 2012 Dec; 115(6):1315-23. PubMed ID: 23144441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours?
    Macias AE
    Infect Control Hosp Epidemiol; 2001 Aug; 22(8):475-6. PubMed ID: 11700869
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of prolonged use of intravenous administration sets in paediatric cancer patients on CVAD-related bloodstream infection rates and hospital resources.
    Simon A; Fleischhack G; Wiszniewsky G; Hasan C; Bode U; Kramer MH
    Infection; 2006 Oct; 34(5):258-63. PubMed ID: 17033749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition.
    Sitges-Serra A; Liñares J; Pérez JL; Jaurrieta E; Lorente L
    JPEN J Parenter Enteral Nutr; 1985; 9(3):322-5. PubMed ID: 3925176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates.
    Reiter PD; Robles J; Dowell EB
    Ann Pharmacother; 2004 Oct; 38(10):1603-7. PubMed ID: 15328398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.